Association of SGLT-2 Inhibition With Size of Myocardial Infarction in Patients With Type 2 Diabetes Mellitus

被引：0
|
作者：
Bojti, Istvan
Bojti, Felicitas
Hartikainen, Tau
Breitbart, Philipp
Valina, Christian
Loffelhardt, Nikolaus
Kaier, Klaus
Wolf, Dennis
Westermann, Dirk
Olivier, Christoph B.
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Diabetes (Type II); Acute coronary syndromes; Percutaneous coronary intervention (PCI);
D O I：
10.1161/circ.148.suppl_1.14605
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A14605
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Role of the Kidney and SGLT-2 Inhibition in Type 2 Diabetes Mellitus
    Miller, Kevin
    Miller, Eden M.
    JOURNAL OF FAMILY PRACTICE, 2015, 64 (12): : S54 - S58
  • [2] Use of SGLT-2 Inhibitors in Patients With Type 1 Diabetes Mellitus
    El Hage, Lea
    Kashyap, Sangeeta R.
    Rao, Pratibha
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2019, 10
  • [3] SGLT-2 Inhibition Does Not Improve Left Ventricular Reverse Remodeling in Patients with Diabetes Mellitus Type 2
    Roy, Swathi
    Lacoste, Andrisael G.
    Zaidi, Bushra
    Hernandez, Nolberto
    Timsina, Lava R.
    Saad, Muhammad
    Bhandari, Manoj
    Bella, Jonathan N.
    Vittorio, Timothy J.
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S12 - S12
  • [4] The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus
    Pitt, Bertram
    Steg, Gabriel
    Leiter, Lawrence A.
    Bhatt, Deepak L.
    CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (03) : 561 - 567
  • [5] Use of SGLT-2 inhibitors in the treatment of type 2 diabetes mellitus
    Santos, Leyna Leite
    Camello De Lima, Fernando Jose
    De Sousa-Rodrigues, Celio Fernando
    Barbosa, Fabiano Timbo
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2017, 63 (07): : 636 - 641
  • [6] Role of the Kidney in Glucose Homeostasis: Implications for SGLT-2 Inhibition in the Treatment of Type 2 Diabetes Mellitus
    Miller, Eden M.
    JOURNAL OF FAMILY PRACTICE, 2017, 66 (02): : S3 - S5
  • [7] Correction to: The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus
    Bertram Pitt
    Gabriel Steg
    Lawrence A. Leiter
    Deepak L. Bhatt
    Cardiovascular Drugs and Therapy, 2022, 36 : 1259 - 1259
  • [8] The SGLT-2 Inhibitors in Personalized Therapy of Diabetes Mellitus Patients
    Tilinca, Mariana Cornelia
    Tiuca, Robert Aurelian
    Tilea, Ioan
    Varga, Andreea
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (12):
  • [9] Overview of the Efficacy and Safety of SGLT-2 Inhibitors in Type 2 Diabetes Mellitus
    Miller, Eden M.
    JOURNAL OF FAMILY PRACTICE, 2017, 66 (02): : S5 - S12
  • [10] Individualizing Treatment With SGLT-2 Inhibitor Therapy in Type 2 Diabetes Mellitus
    Miller, Eden M.
    JOURNAL OF FAMILY PRACTICE, 2017, 66 (02): : S13 - S16
12345